AEON RESPIRE, INC.
Biotech · Private
Inhaled niclosamide formulation for asthma treatment via TMEM16A ion channel inhibition
- Grants
- $2.5M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Inhalation Repurposing of An Approved Drug to Treat Severe Asthma | $276,752 | |
| Federal grant | Department of Health and Human Services · Phase II · Inhalation Repurposing of An Approved Drug to Treat Severe Asthma | $1,193,081 | |
| Federal grant | Department of Health and Human Services · Phase II · Inhalation Repurposing of An Approved Drug to Treat Severe Asthma | $992,767 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1690 | MPEX PHARMACEUTICALS, INC. | — | — |
| 1691 | iQure Pharma Inc. | — | $5.3M |
| 1692 | MicroMGx, Inc. | — | — |
| 1693 | AEON RESPIRE, INC. | — | — |
| 1694 | NEMUCORE MEDICAL INNOVATIONS, INC. | — | — |
| 1695 | Epigen Biosciences, Inc. | — | — |
| 1696 | ONECYTE BIOTECHNOLOGIES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.